Synthesis of 9-substituted sialic acids as probes for CD22-ligand interactions on B cells

ACS Symposium Series

Volumn 960, Issue , 2007, Pages 2-14

  Han, Shoufa ^a   Collins, Brian E ^a   Paulson, James C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36849004855     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-2007-0960.ch001     Document Type: Conference Paper

References (36)

1. Pilatte, Y.; Bignon, J.; Lambre, C. R., Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity. Glycobiology 1993, 3, (3), 201-18.
2. Springer, T. A., Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76, (2), 301-14.
3. Angata, T.; Varki, A., Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. Chem Rev 2002, 102, (2), 439-69.
4. Rogers, G. N.; Herrler, G.; Paulson, J. C.; Klenk, H. D., Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J Biol Chem 1986, 261, (13), 5947-51.
5. Brossmer, R.; Gross, H. J., Fluorescent and photoactivatable sialic acids. Methods Enzymol 1994, 247, 177-93.
6. Brossmer, R.; Gross, H. J., Sialic acid analogs and application for preparation of neoglycoconjugates. Methods Enzymol 1994, 247, 153-76.
7. Kelm, S.; Gerlach, J.; Brossmer, R.; Danzer, C. P.; Nitschke, L., The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J Exp Med 2002, 195, (9), 1207-13.
8. Zaccai, N. R.; Maenaka, K.; Maenaka, T.; Crocker, P. R.; Brossmer, R.; Kelm, S.; Jones, E. Y., Structure-guided design of sialic acid-based Siglec inhibitors and crystallographic analysis in complex with sialoadhesin. Structure (Camb) 2003, 11, (5), 557-67.
9. Luchansky, S. J.; Goon, S.; Bertozzi, C. R., Expanding the diversity of unnatural cell-surface sialic acids. Chembiochem 2004, 5, (3), 371-4.
10. Saxon, E.; Bertozzi, C. R., Cell surface engineering by a modified Staudinger reaction. Science 2000, 287, (5460), 2007-10.
11. Oetke, C.; Brossmer, R.; Mantey, L. R.; Hinderlich, S.; Isecke, R.; Reutter, W.; Keppler, O. T.; Pawlita, M., Versatile biosynthetic engineering of sialic acid in living cells using synthetic sialic acid analogues. J Biol Chem 2002, 277, (8), 6688-95.
12. Cyster, J. G.; Goodnow, C. C., Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity 1997, 6, (5), 509-17.
13. Sato, S.; Miller, A. S.; Inaoki, M.; Bock, C. B.; Jansen, P. J.; Tang, M. L.; Tedder, T. F., CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 1996, 5, (6), 551-62.
14. O'Keefe, T. L.; Williams, G. T.; Davies, S. L.; Neuberger, M. S., Hyperresponsive B cells in CD22-deficient mice. Science 1996, 274, (5288), 798-801.
15. Otipoby, K. L.; Andersson, K. B.; Draves, K. E.; Klaus, S. J.; Farr, A. G.; Kerner, J. D.; Perlmutter, R. M.; Law, C. L.; Clark, E. A., CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 1996, 384, (6610), 634-7.
16. Nitschke, L.; Carsetti, R.; Ocker, B.; Kohler, G.; Lamers, M. C., CD22 is a negative regulator of B-cell receptor signalling. Curr Biol 1997, 7, (2), 133-43.
17. O'Keefe, T. L.; Williams, G. T.; Batista, F. D.; Neuberger, M. S., Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 1999, 189, (8), 1307-13.
18. Powell, L. D.; Jain, R. K.; Matta, K. L.; Sabesan, S.; Varki, A., Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding. J Biol Chem 1995, 270, (13), 7523-32.
19. Razi, N.; Varki, A., Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci USA 1998, 95, (13), 7469-74.
20. Collins, B. E.; Paulson, J. C., Cell surface biology mediated by low affinity multivalent protein-glycan interactions. Curr Opin Chem Biol 2004, 8, (6), 617-25.
21. Jin, L.; McLean, P. A.; Neel, B. G.; Wortis, H. H., Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J Exp Med 2002, 195, (9), 1199-205.
22. Poe, J. C.; Fujimoto, Y.; Hasegawa, M.; Haas, K. M.; Miller, A. S.; Sanford, I. G.; Bock, C. B.; Fujimoto, M.; Tedder, T. F., CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat Immunol 2004, 5, (10), 1078-87.
23. Brossmer, R.; Rose, U.; Kaspar, D.; Smith, T. L.; Grasmuk, H.; Unger, F. M., Enzymic synthesis of 5-acetamido-9-azido-3,5,9-trideoxy-D-glycero-D-galacto- 2-nonulosonic acid, a 9-azido-9-deoxy derivative of N-acetylneuraminic acid. Biochem Biophys Res Commun 1980, 96, (3), 1282-1289.
24. Kong, D. C. M.; Itzstein, M. V., Carbohydr. Res. 1998, 305, 323-329.
25. Han, S., Collins, B. E., Bengtson, P., Paulson, J. C., Homomultimeric complexes of CD22 in B Cells revealed by protein-glycan cross-linking. Nat Chem Biol 2005, 1, (2), 93-97.
26. Marra, A.; Sinay, P., Carbohydr. Res. 1989, 190, 317-322.
27. Marra, A.; Sinay, P., Carbohydr. Res. 1989, 187, 35-42.
28. Blixt, O.; Paulson, J. C., Adv. Synth. Catal. 2003, 345, 687-690.
29. Gross, H. J.; Rose, U.; Krause, J. M.; Paulson, J. C.; Schmid, K.; Feeney, R. E.; Brossmer, R., Transfer of synthetic sialic acid analogues to N- and O-linked glycoprotein glycans using four different mammalian sialyltransferases. Biochemistry 1989, 28, (18), 7386-92.
30. Oetke, C.; Hinderlich, S.; Brossmer, R.; Reutter, W.; Pawlita, M.; Keppler, O. T., Evidence for efficient uptake and incorporation of sialic acid by eukaryotic cells. Eur J Biochem 2001, 268, (16), 4553-61.
31. Keppler, O. T.; Hinderlich, S.; Langner, J.; Schwartz-Albiez, R.; Reutter, W.; Pawlita, M., UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. Science 1999, 284, (5418), 1372-6.
32. Powell, L. D.; Sgroi, D.; Sjoberg, E. R.; Stamenkovic, I.; Varki, A., Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked oligosaccharides with alpha-2,6-linked sialic acids that are required for recognition. J Biol Chem 1993, 268, (10), 7019-27.
33. Law, C. L.; Aruffo, A.; Chandran, K. A.; Doty, R. T.; Clark, E. A., Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells. J Immunol 1995, 155, (7), 3368-76.
34. Greer, S. F.; Justement, L. B., CD45 regulates tyrosine phosphorylation of CD22 and its association with the protein tyrosine phosphatase SHP-1. J Immunol 1999, 162, (9), 5278-86.
35. Fujimoto, M.; Bradney, A. P.; Poe, J. C.; Steeber, D. A.; Tedder, T. F., Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity 1999, 11, (2), 191-200.
36. Collins, B. E.; Blixt, O.; DeSieno, A. R.; Bovin, N.; Marth, J. D.; Paulson, J. C., Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc Natl Acad Sci USA 2004, 101, (16), 6104-9.